FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research
Business Announcement
Updates every hour. Last Updated: 22-Sep-2025 20:11 ET (23-Sep-2025 00:11 GMT/UTC)